glp-1 news past 3 days Weight loss with medicines does not result in a disproportionate loss of muscle mass or function in obese mice and humans: Cell Reports Medicine GLP-1 Drug Savings: A Complete
Description
For this reason, its essential to read ingredient lists and nutrition labels carefully, paying attention to the ratios of macronutrients (carbs, protein, and fat), added sugars, and the vitamin and mineral content

Unlike other DPP-4 inhibitors, linagliptin is renally excreted very little and is not significantly eliminated by the kidneys

However GLP-1s are not currently funded in the South African healthcare setting and so may not be available for that reason

10.1007/s13669-023-00350-1 Curr Obstet Gynecol Rep

Victoza (liraglutide), the first GLP-1 for type 2 diabetes to lose exclusivity in June 2024, may not generate significant savings due to its once-daily dosing and limited market share